Blue Jet Healthcare Limited (BOM:544009)

Market Cap	61.99B -56.4%
Revenue (ttm)	10.53B +20.6%
Net Income	2.94B +25.1%
EPS	16.92 +25.0%
Shares Out	n/a
PE Ratio	21.12
Forward PE	21.08
Dividend	1.20 (0.34%)
Ex-Dividend Date	Sep 19, 2025

Volume	24,515
Average Volume	36,605
Open	342.65
Previous Close	351.00
Day's Range	335.65 - 359.95
52-Week Range	325.20 - 1,028.20
Beta	n/a
RSI	45.66
Earnings Date	May 25, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 196
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In fiscal year 2025, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.